BioCentury
ARTICLE | Clinical News

Pharmacia reports Caverject data

May 2, 2000 7:00 AM UTC

PHA reported clinical results that showed an 81 percent response rate (129 of 159 patients) with Caverject injectable alprostadil intracavarnosal therapy in men with erectile dysfunction (ED) who had ...